Hyperdrive Science is focused on developing and applying its BindFind technology to accelerate the drug development process by rapidly and agnostically identifying the protein targets of drugs and drug candidates. This allows pharmaceutical companies to develop new drugs faster, inform critical decision points in pharmaceutical development, identify off-targets associated with side-effects, deconvolute phenotypic screening results and reposition existing drugs for new uses.

Our mission is to fundamentally change the drug discovery process and work toward a future with cheaper, safer and more effective medicine for everyone.